Patent classifications
A61L2300/604
Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
Disclosed herein is the correlation of chemical properties of oils with the physical properties of a resulting cured oil composition. Also disclosed are biocompatible materials and coatings for medical devices prepared using enriched oils and methods for enhancing or modifying the physical and chemical characteristics of cured oils by enriching such oils with fatty acid alkyl esters. Methods of tailoring the properties of biocompatible materials and coatings to deliver one or more therapeutic agents are also provided.
Intravascular aneurysm treatment device and methods
An intravascular device configured to treat an aneurysm that includes a support structure including metal struts configured to be positioned in a body lumen and defining a central fluid passage that extends axially along the support structure, and a knitted mesh cover disposed over an exterior thereof and across a radial arc and along a length of the support structure sufficient to exceed an opening of an aneurysm to be treated, and the cover includes a polymer fiber having a diameter of at least 40 nanometers to 30 microns and apertures therethrough, the apertures being sized to prevent blood from passing through the device to prevent further expansion of the aneurysm. Devices including apertures that are at least 20 microns and sized to minimize or prevent an aneurysm-filling material from exiting the aneurysm through the knitted mesh cover and support structure, and methods of stenting, are also encompassed.
Process for making controlled release medical implant and non-implant products
A multi-step method of making a mammalian subcutaneous medical implant or non-implant for releasing self-contained drugs on a controlled basis over at least a 3 day period includes depositing at least portions of one or more individual layers of the implant by at least one computer controlled 3-D printer. The 3-D printing method may be accomplished via an array of 3-D nozzles that deposit materials (such as plastics, thermoplastics, coating materials, drug-containing matrix materials, non-drug containing matrix materials, bonding materials, biodegradable materials and/or the like) in very small, precise portions. The materials may be deposited in liquid, powder, sheet or other forms. Non-implant forms may also be provided by the techniques disclosed herein.
Process for making controlled release medical implant products
A method (and the resulting product) of making a medical implant device for releasing self-contained drugs on a controlled basis wherein the method utilizes, at least in part, computer-controlled 3-D printing equipment to deposit via nozzles portions of one or more layers of the medical implant product. The implant has an outer impervious coating, an inner matrix core, an opening and an optional bonding layer.
INTRAOCULAR LENS COMPRISING DRUG-CONTAINING MICROSPHERES
An intraocular lenses having a plurality of drug-containing microspheres attached to the intraocular lens. The intraocular lenses can be used for patients undergoing cataract surgery and reduces the need for recurrent surgery, follow-up treatment or postoperative eye-drops. Also provides a method for manufacturing such an intraocular lens and the use of an intraocular lens in the treatment of cataract.
SYSTEMS AND METHODS FOR TREATING AN ARTICLE INCLUDING A BIODEGRADABLE SUPERABSORBENT MATERIAL
A system for treating used hygienic articles including soiled or swollen superabsorbent materials (SAMs). The portion of the article including the soiled or swollen SAM is treated with a chemical which restructures or degrades the soiled or swollen SAM so that the products of the reaction are easily disposable in a method alternative to trash disposal and landfilling, including through municipal treatment where the products of the reaction do not clog a standard toilet or standard plumbing. Hygienic articles include baby diapers, adult diapers, incontinence pads, menstrual pads, or any other article which includes one or more SAMs.
IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS
A solidifying prepolymeric implant composition comprising a biocompatible prepolymer and an optional filler. One such implant composition is a polyurethane implant composition comprising an isocyanate, such as hydroxymethylenediisocyanate (HMDI) and an alcohol, such as polycaprolactonediol (PCL diol). The compositions of the invention are useful for improving bone structure in patients by applying the solidifying implant composition to bone, reinforcing bone structure, improving load bearing capacity and/or aiding healing of microfractures.
Laminate
A laminate has better handling properties achieved when it is attached to an adherend and which allows the solubility irregularity of the water-soluble material layer to be suppressed. The laminate includes: a 10 to 500 nm thick biodegradable material layer containing an aliphatic polyester and a water-soluble material layer disposed on at least one side of the biodegradable material layer, in which the water-soluble material layer is constituted of a 1 to 20 μm thick first layer containing a water-soluble polymer (a), a 10 μm to 10 mm thick fabric structure containing a water-soluble polymer (b), and a 1 to 20 μm thick second layer containing a water-soluble polymer (c), which are layered in this order from the biodegradable material layer side.
Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
The present invention provides insertable medical devices having elastic surfaces associated with bioactive agent-containing microparticulates and a coating material. Upon expansion of the elastic surfaces the microparticulates can be released to a subject.
Method of treating scoliosis using a biological implant
The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising PTH coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating that is implanted preferably in the convex side of a scoliotically curved spine. The insertion of the biological implant is highly non-invasion, especially as compared to more conventional spine surgical methods, and the biological implant does not decrease spinal mobility or spinal range of motion.